Globus Historical Income Statement

GMED Stock

USD 81.78 1.64 1.97%

Historical analysis of Globus Medical income statement accounts such as Total Revenue of 1.6 B or Gross Profit of 533.4 M can show how well Globus Medical performed in making a profits. Evaluating Globus Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Globus Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Globus Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Globus Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

About Globus Income Statement Analysis

Globus Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Globus Medical shareholders. The income statement also shows Globus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Globus Medical Income Statement Chart

At present, Globus Medical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 1.6 B, whereas EBIT is forecasted to decline to about 163.4 M.

Interest Expense Other Operating Expenses Operating Income Ebitda Cost Of Revenue Income Before Tax

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Globus Medical. It is also known as Globus Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Globus Medical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Globus Medical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Globus Medical income statement and represents the costs associated with goods and services Globus Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Globus Medical income statement and is an important metric when analyzing Globus Medical profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from Globus Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.At present, Globus Medical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 1.6 B, whereas EBIT is forecasted to decline to about 163.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	718.9M	759.1M	1.0B	533.4M
Total Revenue	958.1M	1.0B	1.6B	1.6B

Gross Profit Total Revenue

Globus Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.87	0.99	0.77	1.0	0.29	0.4	0.96	0.68	0.99	0.99	0.42	0.85	0.45	0.03	0.99	0.49	0.28	0.77	-0.58	0.84	0.78	0.84	0.84
Interest Expense	0.87		0.89	0.81	0.88	0.46	0.53	0.88	0.75	0.84	0.9	0.61	0.87	0.69	-0.11	0.91	0.72	0.24	0.96	-0.77	0.97	0.96	0.69	0.6
Total Revenue	0.99	0.89		0.81	1.0	0.42	0.52	0.97	0.76	0.99	1.0	0.54	0.85	0.56	0.08	1.0	0.59	0.31	0.8	-0.59	0.86	0.8	0.82	0.8
Gross Profit	0.77	0.81	0.81		0.78	0.55	0.66	0.82	0.94	0.74	0.8	0.7	0.71	0.75	0.05	0.82	0.72	0.37	0.77	-0.57	0.84	0.86	0.84	0.62
Other Operating Expenses	1.0	0.88	1.0	0.78		0.34	0.45	0.97	0.71	1.0	1.0	0.46	0.85	0.49	0.05	0.99	0.52	0.29	0.78	-0.58	0.84	0.78	0.84	0.83
Operating Income	0.29	0.46	0.42	0.55	0.34		0.92	0.35	0.75	0.29	0.37	0.98	0.43	0.92	0.51	0.4	0.89	0.08	0.5	-0.23	0.49	0.42	0.12	-0.04
Ebit	0.4	0.53	0.52	0.66	0.45	0.92		0.44	0.87	0.4	0.47	0.93	0.35	0.9	0.41	0.5	0.86	0.4	0.58	-0.25	0.56	0.5	0.27	0.12
Research Development	0.96	0.88	0.97	0.82	0.97	0.35	0.44		0.71	0.94	0.98	0.47	0.84	0.54	-0.08	0.97	0.57	0.36	0.8	-0.72	0.9	0.8	0.81	0.73
Ebitda	0.68	0.75	0.76	0.94	0.71	0.75	0.87	0.71		0.67	0.73	0.85	0.6	0.86	0.24	0.75	0.82	0.42	0.75	-0.45	0.77	0.77	0.68	0.48
Cost Of Revenue	0.99	0.84	0.99	0.74	1.0	0.29	0.4	0.94	0.67		0.99	0.41	0.83	0.42	0.08	0.98	0.46	0.26	0.73	-0.52	0.78	0.73	0.84	0.87
Total Operating Expenses	0.99	0.9	1.0	0.8	1.0	0.37	0.47	0.98	0.73	0.99		0.49	0.86	0.53	0.02	1.0	0.56	0.31	0.81	-0.62	0.87	0.81	0.83	0.81
Income Before Tax	0.42	0.61	0.54	0.7	0.46	0.98	0.93	0.47	0.85	0.41	0.49		0.55	0.96	0.43	0.52	0.94	0.13	0.65	-0.35	0.63	0.59	0.28	0.11
Total Other Income Expense Net	0.85	0.87	0.85	0.71	0.85	0.43	0.35	0.84	0.6	0.83	0.86	0.55		0.57	0.09	0.87	0.62	-0.15	0.8	-0.61	0.82	0.81	0.69	0.67
Net Income	0.45	0.69	0.56	0.75	0.49	0.92	0.9	0.54	0.86	0.42	0.53	0.96	0.57		0.18	0.57	0.98	0.24	0.74	-0.54	0.74	0.7	0.32	0.1
Income Tax Expense	0.03	-0.11	0.08	0.05	0.05	0.51	0.41	-0.08	0.24	0.08	0.02	0.43	0.09	0.18		0.02	0.14	-0.35	-0.13	0.53	-0.19	-0.2	-0.05	0.06
Selling General Administrative	0.99	0.91	1.0	0.82	0.99	0.4	0.5	0.97	0.75	0.98	1.0	0.52	0.87	0.57	0.02		0.6	0.31	0.83	-0.63	0.89	0.83	0.82	0.79
Net Income From Continuing Ops	0.49	0.72	0.59	0.72	0.52	0.89	0.86	0.57	0.82	0.46	0.56	0.94	0.62	0.98	0.14	0.6		0.21	0.77	-0.55	0.76	0.71	0.33	0.12
Non Recurring	0.28	0.24	0.31	0.37	0.29	0.08	0.4	0.36	0.42	0.26	0.31	0.13	-0.15	0.24	-0.35	0.31	0.21		0.25	-0.33	0.36	0.24	0.28	0.13
Non Operating Income Net Other	0.77	0.96	0.8	0.77	0.78	0.5	0.58	0.8	0.75	0.73	0.81	0.65	0.8	0.74	-0.13	0.83	0.77	0.25		-0.78	0.94	0.93	0.57	0.48
Tax Provision	-0.58	-0.77	-0.59	-0.57	-0.58	-0.23	-0.25	-0.72	-0.45	-0.52	-0.62	-0.35	-0.61	-0.54	0.53	-0.63	-0.55	-0.33	-0.78		-0.83	-0.75	-0.4	-0.25
Interest Income	0.84	0.97	0.86	0.84	0.84	0.49	0.56	0.9	0.77	0.78	0.87	0.63	0.82	0.74	-0.19	0.89	0.76	0.36	0.94	-0.83		0.93	0.67	0.5
Net Interest Income	0.78	0.96	0.8	0.86	0.78	0.42	0.5	0.8	0.77	0.73	0.81	0.59	0.81	0.7	-0.2	0.83	0.71	0.24	0.93	-0.75	0.93		0.72	0.57
Reconciled Depreciation	0.84	0.69	0.82	0.84	0.84	0.12	0.27	0.81	0.68	0.84	0.83	0.28	0.69	0.32	-0.05	0.82	0.33	0.28	0.57	-0.4	0.67	0.72		0.9
Extraordinary Items	0.84	0.6	0.8	0.62	0.83	-0.04	0.12	0.73	0.48	0.87	0.81	0.11	0.67	0.1	0.06	0.79	0.12	0.13	0.48	-0.25	0.5	0.57	0.9

Click cells to compare fundamentals

Globus Medical Account Relationship Matchups

Globus Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	58.0M	62.9M	69.9M	68.3M	144.7M	152.0M
Interest Expense	17.4M	14.0M	9.3M	14.2M	20.1M	21.1M
Total Revenue	785.4M	789.0M	958.1M	1.0B	1.6B	1.6B
Gross Profit	605.4M	571.6M	718.9M	759.1M	1.0B	533.4M
Other Operating Expenses	608.6M	673.6M	763.2M	786.6M	1.4B	1.5B
Operating Income	172.0M	111.4M	172.0M	228.0M	133.1M	153.7M
Ebit	172.0M	115.5M	180.4M	236.3M	165.4M	163.4M
Research Development	60.1M	84.5M	97.3M	73.0M	124.0M	130.2M
Ebitda	230.0M	178.3M	250.3M	304.5M	310.1M	211.4M
Cost Of Revenue	180.0M	217.5M	239.2M	263.7M	548.2M	575.6M
Total Operating Expenses	428.6M	456.1M	524.0M	522.9M	887.2M	931.5M
Income Before Tax	189.9M	125.9M	180.4M	243.0M	165.4M	162.4M
Total Other Income Expense Net	18.0M	14.5M	8.5M	15.1M	32.3M	33.9M
Net Income	155.2M	102.3M	149.2M	190.2M	122.9M	117.3M
Income Tax Expense	34.7M	23.6M	31.2M	52.9M	42.5M	44.9M
Net Income Applicable To Common Shares	155.2M	102.3M	149.2M	190.2M	218.7M	120.8M
Net Income From Continuing Ops	155.2M	102.3M	149.2M	190.2M	122.9M	131.6M
Tax Provision	34.7M	23.6M	31.2M	52.9M	42.5M	34.9M
Net Interest Income	17.4M	14.0M	9.3M	14.2M	20.1M	13.5M
Reconciled Depreciation	52.7M	62.9M	69.9M	68.3M	144.7M	75.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:

How To Invest In Globus

Details

Is Globus Stock a good investment?

Details

What is Globus Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

42.231

Earnings Share

0.62

Revenue Per Share

18.217

Quarterly Revenue Growth

0.631

Return On Assets

0.0473

The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Globus Historical Income Statement

About Globus Income Statement Analysis

Globus Medical Income Statement Chart

Interest Expense

Other Operating Expenses

Operating Income

Cost Of Revenue

Income Before Tax

Globus Medical income statement Correlations

Globus Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Globus Medical income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Depreciation And Amortization
Other Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Total Revenue
Selling General Administrative	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Total Operating Expenses	+ 1.0	Other Operating Expenses

Interest Income	- 0.83	Tax Provision
Tax Provision	- 0.78	Non Operating Income Net Other
Tax Provision	- 0.77	Interest Expense
Net Interest Income	- 0.75	Tax Provision
Tax Provision	- 0.72	Research Development
Tax Provision	- 0.63	Selling General Administrative